Literature DB >> 35417963

Vascular access complications in patients undergoing veno-arterial ecmo and their impact on survival in patients with refractory cardiogenic shock: A retrospective 8-year study.

Vikrampal Singh1, Gurmeet Singh1, Rajesh Chand Arya2, Samir Kapoor1, Arun Garg1, Sarju Ralhan3, Vivek K Gupta2, Bishav Mohan4, Gurpreet Singh Wander4, Rajiv K Gupta1.   

Abstract

Introduction: Veno-arterial extracorporeal membrane oxygenation (ECMO) is well-recognized treatment modality for patients with refractory cardiogenic shock. Uncomplicated cannulation is a prerequisite and basis for achieving a successful outcome in ECMO. Vascular access is obtained either by surgical cut-down. Common vascular access complications are bleeding and limb ischemia. Objective: To evaluate cannulation technique, the incidence of vascular complications, and their impact on the outcome.
Methods: A retrospective data analysis conducted on 95 patients receiving ECMO from 2013 to 2020 was done. The patients were divided into two groups: no vascular access complications (non-VAC group) and vascular access complications (VAC group). The groups were compared related to the hospital and ICU stays and blood transfusion.
Results: The patients in both groups were demographically and clinically comparable. The Non-VAC group had 75 patients, whereas the VAC group had a total of 20 patients. The main complication observed in the VAC group was bleeding from the cannulation site which required more blood transfusion than the non-VAC group (6.8 ± 1.02 vs 4.2 ± 1.26). Limb ischemia was another complication seen in the VAC group (4.2%, n = 4). Two patients had delayed bleeding after decannulation. The overall average length of stay in the hospital was statistically similar in both the groups (22 days in the VAC group vs 18 days in the non-VAC group), but the average ICU stay was more in the VAC group compared to the non-VAC group (18 days vs 12.06 days).
Conclusion: Bleeding and limb ischemia are the important vascular access site complications, which increase blood transfusion requirements, ICU stay, and overall hospital stay.

Entities:  

Keywords:  Blood transfusion; cannulation; extracorporeal membrane oxygenation (ECMO); veno-arterial ECMO

Mesh:

Year:  2022        PMID: 35417963      PMCID: PMC9244252          DOI: 10.4103/aca.aca_22_22

Source DB:  PubMed          Journal:  Ann Card Anaesth        ISSN: 0971-9784


  15 in total

Review 1.  A meta-analysis of complications and mortality of extracorporeal membrane oxygenation.

Authors:  Alberto Zangrillo; Giovanni Landoni; Giuseppe Biondi-Zoccai; Massimiliano Greco; Teresa Greco; Giacomo Frati; Nicolò Patroniti; Massimo Antonelli; Antonio Pesenti; Federico Pappalardo
Journal:  Crit Care Resusc       Date:  2013-09       Impact factor: 2.159

2.  Venoarterial Extracorporeal Membrane Oxygenation for Acute Fulminant Myocarditis in Adult Patients: A 5-Year Multi-Institutional Experience.

Authors:  Roberto Lorusso; Paolo Centofanti; Sandro Gelsomino; Fabio Barili; Michele Di Mauro; Parise Orlando; Luca Botta; Filippo Milazzo; Guglielmo Actis Dato; Riccardo Casabona; Giovanni Casali; Francesco Musumeci; Michele De Bonis; Alberto Zangrillo; Ottavio Alfieri; Carlo Pellegrini; Sandro Mazzola; Giuseppe Coletti; Enrico Vizzardi; Roberto Bianco; Gino Gerosa; Massimo Massetti; Federica Caldaroni; Emanuele Pilato; Davide Pacini; Roberto Di Bartolomeo; Giuseppe Marinelli; Sandro Sponga; Ugolino Livi; Rinaldi Mauro; Giovanni Mariscalco; Cesare Beghi; Antonio Miceli; Mattia Glauber; Federico Pappalardo; Claudio Francesco Russo
Journal:  Ann Thorac Surg       Date:  2015-10-27       Impact factor: 4.330

3.  Arterial protocol including prophylactic distal perfusion catheter decreases limb ischemia complications in patients undergoing extracorporeal membrane oxygenation.

Authors:  Kathleen M Lamb; Paul J DiMuzio; Adam Johnson; Philip Batista; Neil Moudgill; Megan McCullough; Joshua A Eisenberg; Hitoshi Hirose; Nicholas C Cavarocchi
Journal:  J Vasc Surg       Date:  2017-04       Impact factor: 4.268

4.  Does a distal perfusion cannula reduce ischaemic complications of extracorporeal membrane oxygenation?

Authors:  Robert Wai-Leung Ma; Ravi L Huilgol; Emily Granger; Andrew Jackson; Samantha Saling; Ashraf Dower; Ian Nivison-Smith
Journal:  ANZ J Surg       Date:  2016-02-28       Impact factor: 1.872

5.  The Impact of Vascular Complications on Survival of Patients on Venoarterial Extracorporeal Membrane Oxygenation.

Authors:  Daizo Tanaka; Hitoshi Hirose; Nicholas Cavarocchi; John W C Entwistle
Journal:  Ann Thorac Surg       Date:  2016-02-10       Impact factor: 4.330

6.  Vascular complications in patients undergoing femoral cannulation for extracorporeal membrane oxygenation support.

Authors:  Theodosios Bisdas; Gernot Beutel; Gregor Warnecke; Marius M Hoeper; Christian Kuehn; Axel Haverich; Omke E Teebken
Journal:  Ann Thorac Surg       Date:  2011-05-08       Impact factor: 4.330

7.  Lower-extremity complications with femoral extracorporeal life support.

Authors:  Prashanth Vallabhajosyula; Matthew Kramer; Sofiane Lazar; Fenton McCarthy; Eduardo Rame; Joyce Wald; Wilson Szeto; Matthew Williams; Pavan Atluri; Nimesh Desai; Michael Acker
Journal:  J Thorac Cardiovasc Surg       Date:  2016-03-03       Impact factor: 5.209

8.  Identifying the Risk Factor and Prevention of Limb Ischemia in Extracorporeal Membrane Oxygenation with Femoral Artery Cannulation.

Authors:  Chih-Chien Yen; Chih-Hong Kao; Chien-Sung Tsai; Shin-Han Tsai
Journal:  Heart Surg Forum       Date:  2018-01-16       Impact factor: 0.676

Review 9.  Review of ECMO (extra corporeal membrane oxygenation) support in critically ill adult patients.

Authors:  Silvana F Marasco; George Lukas; Michael McDonald; James McMillan; Benno Ihle
Journal:  Heart Lung Circ       Date:  2008-10-29       Impact factor: 2.975

10.  Vascular complications in adult postcardiotomy cardiogenic shock patients receiving venoarterial extracorporeal membrane oxygenation.

Authors:  Feng Yang; Dengbang Hou; Jinhong Wang; Yongchao Cui; Xiaomeng Wang; Zhichen Xing; Chunjing Jiang; Xing Hao; Zhongtao Du; Xiaofang Yang; Yu Jiang; Xiaotong Hou
Journal:  Ann Intensive Care       Date:  2018-06-19       Impact factor: 6.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.